-30%

BUXOM Plump Shot Peptide Plumping Blush, Lightweight Matte Cream-to-Powder, Medium Buildable Color, Peptide-Infused Formula, Soft-Focus Finish, Cruelty-Free


$19.60 $28.00

BUXOM Plump Shot Peptide Plumping Blush, Lightweight Matte Cream-to-Powder, Medium Buildable Color, Peptide-Infused Formula, Soft-Focus Finish, Cruelty-Free

From the brand

bg_dbg_d

#1_plumping#1_plumping

Major Savings On Buxom’s Faves

plumping_revolutionplumping_revolution

New Season, New Obsessions

newnew

meetbuxommeetbuxom

big bold sexybig bold sexy

Package Dimensions ‏ : ‎ 2.36 x 2.32 x 0.67 inches; 1.45 ounces
UPC ‏ : ‎ 194249006203
Manufacturer ‏ : ‎ Buxom
ASIN ‏ : ‎ B0CYVD9QCH
Best Sellers Rank: #72,721 in Beauty & Personal Care (See Top 100 in Beauty & Personal Care) #290 in Face Blushes
Customer Reviews: 4.4 4.4 out of 5 stars 60 ratings var dpAcrHasRegisteredArcLinkClickAction; P.when(‘A’, ‘ready’).execute(function(A) { if (dpAcrHasRegisteredArcLinkClickAction !== true) { dpAcrHasRegisteredArcLinkClickAction = true; A.declarative( ‘acrLink-click-metrics’, ‘click’, { “allowLinkDefault”: true }, function (event) { if (window.ue) { ue.count(“acrLinkClickCount”, (ue.count(“acrLinkClickCount”) || 0) + 1); } } ); } }); P.when(‘A’, ‘cf’).execute(function(A) { A.declarative(‘acrStarsLink-click-metrics’, ‘click’, { “allowLinkDefault” : true }, function(event){ if(window.ue) { ue.count(“acrStarsLinkWithPopoverClickCount”, (ue.count(“acrStarsLinkWithPopoverClickCount”) || 0) + 1); } }); });

Customers say

Customers like the blush’s color, describing it as a perfect cream shade. The product receives positive feedback for its application, with one customer noting it goes on smoothly with a brush. They appreciate its consistency, with one mentioning it blends easily, and find it lasts all day.

Based on 0 reviews

0.0 overall
0
0
0
0
0

Be the first to review “BUXOM Plump Shot Peptide Plumping Blush, Lightweight Matte Cream-to-Powder, Medium Buildable Color, Peptide-Infused Formula, Soft-Focus Finish, Cruelty-Free”

There are no reviews yet.